ZTALMY® Q3 net product revenue of $5.4 million; 2023 net product revenue guidance increased to between $18.5 and $19 million
Over 75% of patients required for the interim analysis are now.
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) is set to release its earnings data before the market opens on Tuesday, November 7th. Analysts expect Marinus Pharmaceuticals to post earnings of ($0.67) per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Marinus Pharmaceuticals […]
Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. […]